Dashboard
Manage Tickers

RGENREPLIGEN CORP

Nasdaq repligen.com


$ 120.79 $ 0.63 (0.52 %)    

Wednesday, 03-Jul-2024 12:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 120.77
$ 122.31
$ 0.00 x 0
$ 0.00 x 0
$ 120.69 - $ 123.67
$ 110.45 - $ 211.13
277,299
na
6.83B
$ 1.13
$ 460.00
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-27-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 03-17-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-robinhood-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday
This Robinhood Analyst Turns Bullish; Here...
06/26/2024 12:44:01

Core News & Articles
NVIDIA To Rally Around 19%? Here Are 10 To...
06/26/2024 12:12:59

deutsche-bank-upgrades-repligen-to-buy-lowers-price-target-to-155
Deutsche Bank Upgrades Repligen to Buy, Lo...
06/26/2024 10:30:30

Deutsche Bank analyst Justin Bowers upgrades Repligen (NASDAQ:RGEN) from Hold to Buy and lowers the price target from $180 t...

top-3-health-care-stocks-that-could-blast-off-in-june
Top 3 Health Care Stocks That Could Blast ...
06/21/2024 12:22:06

guggenheim-initiates-coverage-on-repligen-with-neutral-rating
Guggenheim Initiates Coverage On Repligen ...
06/18/2024 10:45:08

Guggenheim analyst Subbu Nambi initiates coverage on Repligen (NASDAQ:RGEN) with a Neutral rating.

why-signet-jewelers-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Signet Jewelers Shares Are Trading Low...
06/13/2024 18:07:39

repligen-appoints-olivier-loeillot-as-chief-executive-officer-effective-september-1-2024
Repligen Appoints Olivier Loeillot As Chie...
06/13/2024 11:07:18

Board of Directors approved the planned transition of Tony J. Hunt from Chief Executive Officer ("CEO") to Executive Ch...

Core News & Articles
Ecolab Life Sciences And Repligen Launch D...
06/03/2024 12:20:26

Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences comp...

jp-morgan-maintains-overweight-on-repligen-lowers-price-target-to-200
JP Morgan Maintains Overweight on Repligen...
05/02/2024 16:45:36

JP Morgan analyst Rachel Vatnsdal maintains Repligen (NASDAQ:RGEN) with a Overweight and lowers the price target from $230 t...

repligen-reaffirms-2024-adjusted-eps-guidance-of-142-149-versus-consensus-of-146
Repligen Reaffirms 2024 Adjusted EPS Guida...
05/01/2024 11:35:30

repligen-reaffirms-2024-sales-guidance-of-620m-650m-versus-consensus-of-63779m
Repligen Reaffirms 2024 Sales Guidance Of ...
05/01/2024 11:34:32

repligen-q1-2024-adj-eps-028-misses-030-estimate-sales-151346m-beat-150062m-estimate
Repligen Q1 2024 Adj EPS $0.28 Misses $0.3...
05/01/2024 11:32:30

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.30 by 6...

healthstream-reports-upbeat-results-joins-spotify-ryder-system-and-other-big-stocks-moving-higher-on-tuesday
HealthStream Reports Upbeat Results, Joins...
04/23/2024 14:50:19

aehr-test-systems-reports-preliminary-results-joins-dyne-therapeutics-united-airlines-and-other-big-stocks-moving-lower-on-monday
Aehr Test Systems Reports Preliminary Resu...
03/25/2024 14:32:02

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

whats-going-on-with-life-science-focused-repligen-stock-today
What's Going On With Life Science-Focused ...
02/21/2024 15:25:07

Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new m...

repligen-shares-are-trading-lower-after-the-company-issued-weak-guidance-for-2024
Repligen shares are trading lower after th...
02/21/2024 13:17:51

repligen-expects-fiscal-year-2024-adjusted-eps-of-142---149-versus-consensus-of-177
Repligen Expects Fiscal Year 2024 Adjusted...
02/21/2024 12:36:50

repligen-expects-fiscal-year-2024-revenue-of-620m-650m-versus-consensus-of-66068m
Repligen Expects Fiscal Year 2024 Revenue ...
02/21/2024 12:36:25

repligen-q4-adjusted-eps-033-inline-sales-15574m-beat-15539m-estimate
Repligen Q4 Adjusted EPS $0.33, Inline, Sa...
02/21/2024 12:31:58

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.33 per share which met the analyst consensus estimate. This is a 51.47...

earnings-scheduled-for-february-21-2024
Earnings Scheduled For February 21, 2024
02/21/2024 10:09:04

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)